Feature Channels: Alzheimer's and Dementia

• share
• favorite_border

Studies by researchers at UTHealth Houston seeking to understand the underlying pathology of Alzheimer’s disease in order to discover new pathways to treatment have earned multiple awards totaling $3.5 million from the Texas Alzheimer’s Research and Care Consortium (TARCC).

• share
• favorite_border

Studies that find a reduction in dementia risk through lifestyle changes and treatments are frequently reported in the news. Professor Eef Hogervost wearing a green patterened dress and stood in front of an office space that is purple and green colour schemed. Professor Eef Hogervorst. While such findings are important and should be shared with the public, they must be communicated with care, says Professor Eef Hogervorst, a neuropsychologist and epidemiologist specialising in dementia research. In this expert comment piece, Professor Hogervorst discusses the complex factors that influence dementia risk and why we must not oversimplify research findings by presenting lifestyle changes and treatments as straightforward solutions that will work for everyone.

• share
• favorite_border

A class of drugs for diabetes may be associated with a lower risk of dementia and Parkinson’s disease, according to a study published in the September 18, 2024, online issue of Neurology®, the medical journal of the American Academy of Neurology.

• share
• favorite_border

• share
• favorite_border

Two new papers by an international team of researchers demonstrate that evaluating microRNAs in blood can be used not only to diagnose mild cognitive impairment (MCI) but also to predict the conversion from MCI to dementia due to Alzheimer's disease.

• share
• favorite_border

A groundbreaking study using a tiny roundworm could pave the way for new treatments for neurodegenerative disorders. Researchers have linked the worm gene swip-10 to copper regulation – a vital element for brain health found in everyday items like wiring and cookware. Understanding the roles of swip-10 and MBLAC1, a protein involved in processing cellular materials, could lead to the development of effective medications and opens new avenues for advancing brain disease treatments.

• share
• favorite_border

Mount Sinai Health System today announced that they will be among the first in the world to deploy blood-based biomarkers (blood tests) and confirmatory tests for Alzheimer’s disease and related dementias to patients across primary and specialty care settings—early detection tools that have never before been offered to patients in the clinical setting—as part of the Davos Alzheimer’s Collaborative (DAC) Healthcare System Preparedness Accurate Diagnosis project.

• share
• favorite_border

Wellesley team’s new research on anesthesia unlocks important clues about the nature of consciousness

• share
• favorite_border

Participating in a series of cognitive training sessions has helped Quebec seniors cope with memory loss - even five years later, an UdeM study finds.

• share
• favorite_border

Outdoor light at night could be a significant risk factor in Alzheimer’s disease, according to new research from Rush.

• share
• favorite_border

Researchers have for the first time identified degeneration-associated “molecular markers” – observable changes in cells and their gene-regulating networks – that are shared by several forms of dementia that affect different regions of the brain.

• share
• favorite_border

Violent blows or jolts to the head can cause traumatic brain injury (TBI), and there are currently about five million people in the U.S. living with chronic neurodegeneration and related impairments due to TBI.

• share
• favorite_border

This $11 million IHS contract will create training for healthcare providers and support patients’ families in communities that have little access to such specialized care.

• share
• favorite_border

• share
• favorite_border

The 14th annual Markesbery Symposium on Aging and Dementia is set for Sept. 27-28. The symposium, hosted by UK’s Sanders-Brown Center on Aging, is named in honor and memory of the late William R. Markesbery, M.D., the founding director of Sanders-Brown.

• share
• favorite_border

Three recently published studies from Cedars-Sinai investigators have deepened knowledge of how changes in the eye are linked to indicators of Alzheimer’s disease in the brain.

• share
• favorite_border

Andy Groves, PhD, a leading researcher in the development of the inner ear, will head the Department of Developmental Biology at Washington University School of Medicine in St. Louis beginning in April.